about
Return on investment of a work-family intervention: evidence from the Work, Family, and Health NetworkHealthcare utilization of individuals with opiate use disorders: an analysis of integrated medicaid and state mental health/substance abuse agency dataAlcohol drinking patterns and health care utilization in a managed care organization.The effect of alcohol treatment on social costs of alcohol dependence: results from the COMBINE study.Impact of Illicit Drug Use on Health-Related Quality of Life in Opioid-Dependent Patients Undergoing HIV Treatment.Mental health and substance abuse treatment utilization among individuals served by multiple public agencies in 3 states.Quality of life as an outcome of opioid use disorder treatment: A systematic review.A systematic review and meta-analysis of health care utilization outcomes in alcohol screening and brief intervention trials.Short term health-related quality of life improvement during opioid agonist treatmentThe effect of screening and brief intervention for risky drinking on health care utilization in managed care organizations.Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse.Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population.Cost and Return on Investment of a Work-Family Intervention in the Extended Care Industry: Evidence From the Work, Family, and Health Network.The Impact of a Mandated Trauma Center Alcohol Intervention on Readmission and Cost per Readmission in Arizona.The relative impact of brief treatment versus brief intervention in primary health-care screening programs for substance use disorders.Sustaining SBIRT in the wild: simulating revenues and costs for Screening, Brief Intervention and Referral to Treatment programs.The influence of state-level policy environments on the activation of the Medicaid SBIRT reimbursement codes.Substance use outcomes of patients served by a large US implementation of Screening, Brief Intervention and Referral to Treatment (SBIRT).Screening, Brief Intervention and Referral to Treatment (SBIRT): rationale, program overview and cross-site evaluation.Prevalence and costs of major depression among elderly claimants with diabetes.Cost of Screening, Brief Intervention, and Referral to Treatment in Health Care Settings.Cost of employee assistance programs: comparison of national estimates from 1993 and 1995.The joint demand for cigarettes and marijuana: evidence from the National Household Surveys on Drug Abuse.The 'Outcome Reporting in Brief Intervention Trials: Alcohol' (ORBITAL) framework: protocol to determine a core outcome set for efficacy and effectiveness trials of alcohol screening and brief intervention.Screening, Brief Intervention and Referral to Treatment: implications of SAMHSA's SBIRT initiative for substance abuse policy and practice.The cost-effectiveness of brief intervention versus brief treatment of Screening, Brief Intervention and Referral to Treatment (SBIRT) in the United States.Joint Utility Estimators in Substance Use Disorders.Alcohol use and the wage returns to education and work experience.Effects of a Flexibility/Support Intervention on Work Performance.The Relationship Between End-of-Treatment Alcohol Use and Subsequent Healthcare Costs: Do Heavy Drinking Days Predict Higher Healthcare Costs?A time and motion study of Screening, Brief Intervention, and Referral to Treatment implementation in health-care settings.The Cost-effectiveness of Alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) in Emergency and Outpatient Medical Settings.Do treatment services for drug users in outpatient drug-free treatment programs affect employment and crime?The effect of treatment completion and length of stay on employment and crime in outpatient drug-free treatment.Prescription Drug Abuse and Workplace Absenteeism: Evidence from the 2008–2012 National Survey on Drug Use and HealthAn Alcohol Policy Trifecta: Reduce Alcohol Problems, Save on Health Care, Generate Public RevenuesBRIEF INTERVENTIONS FOR AT-RISK DRINKING: PATIENT OUTCOMES AND COST-EFFECTIVENESS IN MANAGED CARE ORGANIZATIONSThe costs of screening and brief intervention for risky alcohol useLatent variable models of alcohol-related constructsThe differential effects of alcohol consumption and dependence on adverse alcohol-related consequences: implications for the workforce
P50
Q23910871-E4913A92-5B7D-4458-B02D-24DDD95EEB5CQ31115026-EA40EF5D-3B3C-4557-AE39-97A9E6F48EF1Q34336479-88D53D40-1858-4A78-A1A0-4209BB733AB7Q35087485-3AA84699-6C62-4084-AE96-9F148713C16FQ36167178-774B3263-5895-4209-863E-4CC08A634F3AQ36190242-10CFA2A8-D6EF-43F0-9E4F-7751420521EFQ36278101-77986388-CFFC-44A7-8467-1FD21A5C4CB8Q36405424-732A0135-B63F-4184-AC17-5F84E6DACCEEQ36652120-999D33FA-B8FC-460E-9EE3-0DA79EE33134Q36708816-0BD47A1F-B001-488F-8DFA-9E98145277E9Q37031150-A9A5D651-ADE9-4F3C-9FEC-9244635288DBQ37279124-818622A7-0004-4758-897D-28C69FE45600Q38649322-B7E78544-2AD7-4A4F-B70D-D1D608ACC5BBQ38996425-59A9F528-BEBB-404B-962C-19F5945BA7C0Q39027791-0424A932-7CFC-4128-B24B-0804BC7CA012Q39027798-1CFD0E88-040D-4DC6-A2F6-64A5B7A05EB3Q39027801-577F222B-4BAE-46B4-8D58-647EC187B825Q39027805-3B0BAB9B-C979-4B8F-8F77-762FA8AA8B89Q39079174-56DDCC93-EF1D-4865-84D8-310B6BE03FE6Q40608514-2812DF82-D119-49CF-84AA-974FB7327FEFQ40752780-25DB8CD7-E9D3-4763-8B1A-667830FD7FFAQ40822146-EADECF37-5847-40F7-B2D6-A9983F78DD18Q43517175-AE60E3F1-84AD-417A-8ADE-A467AF184C35Q47166773-98E3428D-2A25-406D-8001-AC00E556D08AQ47831966-B13AB99C-97E4-4775-AD3D-6D0BC7756F4FQ47831981-BAF4835E-472C-4EB1-A173-7D85194CC6F3Q47946019-26D5556F-1D11-42A5-BEEB-CC1534C4E9F8Q48190190-670EBE3E-B617-4B23-960A-A56B46FD5D3DQ48622494-DEBD57C2-0512-43DB-B6E3-E8EE08B0BE4AQ50216087-8CC03FE3-206B-4FF2-ABA5-A59F47EE52A4Q50958987-263057AA-2F47-471C-9EA8-4097AE738660Q50963004-9F933582-7F88-4AE7-9E1E-69C97B631511Q53565806-2DA60A3B-7DDE-4C20-965D-F1833C431CB6Q53661065-3A231970-D2DD-407E-BBDD-5541E8B4CE6EQ57200161-CAD0B494-67FE-4DAE-A9CD-78AC605E8541Q60941236-5587CF4C-A0EE-4385-8ACF-18C77755B52FQ60941361-150C8540-3FEF-4DC1-816B-9ED36017251CQ60941403-D519FB33-8F7E-4684-ADB8-A2FD79C307F4Q71704841-F59CF90D-2238-4BF7-B866-F510E7CF0D6EQ74741310-C961E51D-7A04-48CC-83F7-A21819DAB250
P50
description
researcher ORCID ID = 0000-0001-7712-160X
@en
wetenschapper
@nl
name
Jeremy Bray
@ast
Jeremy Bray
@en
Jeremy Bray
@es
Jeremy Bray
@nl
type
label
Jeremy Bray
@ast
Jeremy Bray
@en
Jeremy Bray
@es
Jeremy Bray
@nl
prefLabel
Jeremy Bray
@ast
Jeremy Bray
@en
Jeremy Bray
@es
Jeremy Bray
@nl
P106
P1153
7102443172
P31
P496
0000-0001-7712-160X